• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗克氏锥虫的咪唑类化合物

New Imidazole-Based Compounds Active Against Trypanosoma cruzi.

作者信息

Adeyemi Oluyomi Stephen, Molina María Teresa, Eseola Abiodun Omokehinde, Fonseca-Berzal Cristina, Gómez-Barrio Alicia

机构信息

Medicinal Biochemistry and Toxicology Laboratory, Department of Biological Sciences, PMB 1004, Landmark University, Omu-Aran. Nigeria.

Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 3, 28006, Madrid. Spain.

出版信息

Comb Chem High Throughput Screen. 2017;20(1):20-24. doi: 10.2174/1386207320666170110141907.

DOI:10.2174/1386207320666170110141907
PMID:28071587
Abstract

BACKGROUND

Current drugs available for the treatment of Chagas disease are fraught with several challenges including severe toxicity and limited efficacy. These factors coupled with the absence of effective drugs for treating the chronic stage of the disease have rendered the development of new drugs against Chagas disease a priority.

OBJECTIVE

This study screened several imidazole-based compounds for anti-Trypanosoma potential.

METHOD

Using an in vitro experimental infection model, several imidazole-based compounds were screened for anti-proliferative effect on Trypanosoma cruzi epimastigotes. Additionally, all test compounds were evaluated for unspecific cytotoxicity on L929 murine fibroblasts. Benznidazole (BZN) served as reference drug.

RESULTS

All test compounds demonstrated interesting trypanocidal potential with IC50 values in the μM range (1< 1C50 <8 μM). The activities of the test compounds compared favorably with BZN, which had an IC50 value ca. 30 μM. Conversely, most of the test compounds were highly cytotoxic, resulting in selectivity lower than that of BZN (SI > 9.42).

CONCLUSION

We provide evidence which implicate the imidazole-based compounds as potential prototypes for the development of anti-parasitic agents. Findings have far-reaching relevance to drug discovery efforts for trypanosomiasis.

摘要

背景

目前可用于治疗恰加斯病的药物面临诸多挑战,包括严重的毒性和有限的疗效。这些因素,再加上缺乏治疗该疾病慢性阶段的有效药物,使得开发抗恰加斯病的新药成为当务之急。

目的

本研究筛选了几种基于咪唑的化合物的抗锥虫潜力。

方法

使用体外实验感染模型,筛选了几种基于咪唑的化合物对克氏锥虫前鞭毛体的抗增殖作用。此外,评估了所有测试化合物对L929小鼠成纤维细胞的非特异性细胞毒性。苯硝唑(BZN)作为参考药物。

结果

所有测试化合物均显示出有趣的杀锥虫潜力,IC50值在微摩尔范围内(1 < IC50 < 8 μM)。测试化合物的活性与IC50值约为30 μM的BZN相比具有优势。相反,大多数测试化合物具有高度细胞毒性,导致选择性低于BZN(SI > 9.42)。

结论

我们提供的证据表明,基于咪唑的化合物是开发抗寄生虫药物的潜在原型。这些发现对锥虫病的药物发现工作具有深远意义。

相似文献

1
New Imidazole-Based Compounds Active Against Trypanosoma cruzi.新型抗克氏锥虫的咪唑类化合物
Comb Chem High Throughput Screen. 2017;20(1):20-24. doi: 10.2174/1386207320666170110141907.
2
Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.2,4-二芳基-1,2,3,4-四氢喹啉类化合物对表达β-半乳糖苷酶的克氏锥虫滋养体和无鞭毛体的选择性作用。
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4851-6. doi: 10.1016/j.bmcl.2013.06.079. Epub 2013 Jul 12.
3
Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.在克氏锥虫Y株诱导的恰加斯病瑞士小鼠模型中,甾醇14α-去甲基酶(CYP51)抑制剂VNI和VFV的抗锥虫活性
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02098-16. Print 2017 Apr.
4
Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.抗克氏锥虫药物苯硝唑的新型多晶型物。
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 24;118:389-94. doi: 10.1016/j.saa.2013.08.096. Epub 2013 Sep 5.
5
Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity.新型2-芳基偶氮咪唑衍生物作为克氏锥虫增殖抑制剂:其生物活性的合成与评价
Eur J Med Chem. 2017 Jan 5;125:327-334. doi: 10.1016/j.ejmech.2016.09.045. Epub 2016 Sep 15.
6
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.体外和体内研究抗寄生虫药甾醇 14α-去甲基酶(CYP51)抑制剂 VNI 对克氏锥虫耐药株的抗寄生虫活性。
Antimicrob Agents Chemother. 2013 Sep;57(9):4151-63. doi: 10.1128/AAC.00070-13. Epub 2013 Jun 17.
7
Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.恰加斯病的实验模型:用于筛选抗克氏锥虫化合物的方法学综述
Parasitol Res. 2018 Nov;117(11):3367-3380. doi: 10.1007/s00436-018-6084-3. Epub 2018 Sep 19.
8
Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.针对克氏锥虫的噻唑类化合物的结构设计、合成及药理学评价
Eur J Med Chem. 2017 Dec 1;141:346-361. doi: 10.1016/j.ejmech.2017.09.047. Epub 2017 Sep 22.
9
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi and .药物再利用治疗恰加斯病:氯喹增强苯硝唑对克氏锥虫的活性。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0028422. doi: 10.1128/aac.00284-22. Epub 2022 Oct 31.
10
Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.新型基于硝基(三唑/咪唑)的杂芳基酰胺/磺酰胺作为潜在的抗锥虫剂。
Eur J Med Chem. 2014 Nov 24;87:79-88. doi: 10.1016/j.ejmech.2014.09.045. Epub 2014 Sep 16.

引用本文的文献

1
Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies.咪唑衍生的烷基和芳基醚:合成、表征、体外抗癌和抗氧化活性、碳酸酐酶I-II抑制特性及计算机模拟研究
ACS Omega. 2024 May 3;9(19):20937-20956. doi: 10.1021/acsomega.4c00028. eCollection 2024 May 14.
2
Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.针对 SARS-CoV-2 的一系列新型咪唑衍生物治疗潜力的计算研究。
J Pharmacol Sci. 2021 Sep;147(1):62-71. doi: 10.1016/j.jphs.2021.05.004. Epub 2021 May 23.
3
New Series of Imidazoles Showed Promising Growth Inhibitory and Curative Potential Against Trypanosoma Infection.
一系列新型咪唑类化合物在抑制和治疗锥虫感染方面显示出了良好的效果。
Yale J Biol Med. 2021 Jun 30;94(2):199-207. eCollection 2021 Jun.
4
Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.筛选抑制弓形虫生长和侵袭的化合物库。
Parasitol Res. 2020 May;119(5):1675-1681. doi: 10.1007/s00436-020-06673-9. Epub 2020 Apr 1.
5
Screening to Identify Anti- Compounds and Modeling for Bioactivities and Toxicity.筛选鉴定抗化合物及生物活性和毒性建模。
Yale J Biol Med. 2019 Sep 20;92(3):369-383. eCollection 2019 Sep.
6
Screening of chemical compound libraries identified new anti-Toxoplasma gondii agents.对化合物文库的筛选鉴定出了新的抗刚地弓形虫药物。
Parasitol Res. 2018 Feb;117(2):355-363. doi: 10.1007/s00436-017-5698-1. Epub 2017 Dec 19.